CB Therapeutics has been awarded two additional patents for its breakthrough biosynthesis platform. These patents cover new cellular agriculture advances for producing high value compounds. CB Therapeutics is building the largest collection of biosynthetic cannabinoids, psychedelics, and their analogs, the PsyVault . SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics is a leading biosynthesis company…


Previous articlePT259 – Dr. Devon Christie and Will Siu, MD, DPhil – The Mind-Body Connection, MDMA, and Chronic Pain
Next articleMindset Pharma Broadens its IP Portfolio by Filing U.S. Provisional Patent Extending its DMT and 5-MeO-DMT Inspired Psychedelic Drug Candidates